Digital submission of adverse event reports for investigational new drug applications
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
First vaccine to protect against Ebola
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA approves new treatment for patients with migraine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first oral GLP-1 treatment for type 2 diabetes
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA takes first action under new international collaboration with Australia and Canada
- FDA approves first treatment for patients with rare type of lung disease
- EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US
- FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
- FDA approves first therapy for rare joint tumor
- FDA approves first treatment for severe hypoglycemia that can be administered without an injection
- FDA approves first generics of Lyrica